Eterna Therapeutics
ERNA
#10043
Rank
$13.85 M
Marketcap
$0.27
Share price
-3.25%
Change (1 day)
-88.72%
Change (1 year)

Eterna Therapeutics (ERNA) - P/B ratio

P/B ratio as of March 2025 : -0.3051

According to Eterna Therapeutics's latest financial reports the company has a price-to-book ratio of 23.1607.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Eterna Therapeutics - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31-0.2863-106.58%
2023-12-314.35218.94%
2022-12-311.36-83.98%
2021-12-318.51
2020-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.51-923.85%๐Ÿ‡บ๐Ÿ‡ธ USA
3.93-1,388.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.35 998.87%๐Ÿ‡บ๐Ÿ‡ธ USA
1.83-699.51%๐Ÿ‡ซ๐Ÿ‡ท France
4.78-1,666.22%๐Ÿ‡บ๐Ÿ‡ธ USA
3.03-1,092.02%๐Ÿ‡ฆ๐Ÿ‡บ Australia
3.30-1,181.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel